Telstra's H1 release surprised through an additional share buyback and analysts' confidence in ongoing dividend increases has ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2024 and ...

Risks from paper checks are at an all-time high, and here's why: ...

No GMAT/GRE scores are required. The Rutgers Business School Master of Accountancy in Taxation is a 30-credit, online-hybrid, part-time program designed for the busy, working professional. It is ...

Fourth quarter 2024 net sales of Qelbree® increased 60% to $74.4 million, compared to the same period in 2023. Full year 2024 net sales of ...

Bgin Blockchain plans a $50M IPO to expand crypto mining amid growth, but faces market volatility, legal disputes, and risks.

In some cases, it'll work out better if you let it go instead of trying to force a deadbeat client, patient or customer to ...

Net loss was $18.9 million for the fourth quarter of 2024, compared to a loss of $27.5 million in the prior year period. Adjusted EBITDA was a loss of $10.3 million for the fourth quarter of 2024, ...

The UK’s Climate Change Committee (CCC) has today (26 February) presented a new pathway to decarbonise all sectors on the ...

Regulator Urges Households To Switch And Fix Around 22 million households in England, Wales and Scotland will see their annual bills rise b ...

Hims & Hers Health, Inc. showcases strong growth with diverse revenue streams. Discover why its stock dip offers a unique opportunity. Learn more on HIMS stock here.

Record total revenues of $4.1 billion in 2024 and $1.1 billion in 4Q24 -- Xywav® and Epidiolex® revenues grew 16% and 15% year-over-year, respectively, in 2024 -- Oncology revenues grew 9% ...